Learn more

DEUTERX LLC

Overview
  • Total Patents
    53
  • GoodIP Patent Rank
    31,318
  • Filing trend
    ⇩ 37.0%
About

DEUTERX LLC has a total of 53 patent applications. It decreased the IP activity by 37.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are TIANJIN HEMAY PHARMACEUTICAL SCI TECH CO LTD, BALANCE THERAPEUTICS INC and TUNG ROGER.

Patent filings per year

Chart showing DEUTERX LLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Dewitt Sheila 45
#2 Jacques Vincent 21
#3 Van Der Ploeg Leonardus H T 12
#4 Van Der Ploeg Leonardus 6
#5 Czarnik Anthony W 5
#6 Sheila Dewitt 1

Latest patents

Publication Filing date Title
WO2019126704A1 Deuterium-enriched isoindolinonyl-azepanediones and related compounds and methods of treating medical disorders using same
US9809603B1 Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
WO2016153949A1 5-deutero-thiazolidine-2,4-dione compounds and methods of treating medical disorders using same
WO2016153952A1 Methods of treating bacterial infections and fungal infections using enantiopure deuterium-enriched pioglitazone
WO2016153948A1 Combination therapy using enantiopure, oxy-substituted, deuterium-enriched 5-(benzyl)-5-deutero-thiazolidine-2, 4-diones for treatment of medical disorders
WO2016153951A1 5-deutero-thiazolidinyldione compounds and methods of treating medical disorders using same
WO2015109037A1 Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
US2016311757A1 Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion
WO2014152833A1 3-(substituted-4-oxo-quinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives
EP2968298A1 Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
US2014221369A1 5-deutero-2,4-thiazolidinedione and 5-deutero-2,4-oxazolidinedione derivatives and compositions comprising and methods of using the same
AU2014205043A1 3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives
AU2012236655A1 2',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compounds